Stat3/Stat5 Signaling Antibody Sampler Kit #67088
Product Information
Kit Usage Information
Protocols
- 3230: Western Blotting, Immunoprecipitation (Agarose), Immunohistochemistry (Paraffin)
- 4322: Western Blotting, IF Protocol with Methanol Permeabilization, Flow Cytometry, BSA-free Methanol Permeabilization Protocol
- 4406: Western Blotting, Fluorescent Western
- 7074: Western Blotting
- 9145: Western Blotting, Fluorescent Western, Immunoprecipitation (Agarose), Immunohistochemistry (Leica® Bond™), Immunohistochemistry (Paraffin), Immunofluorescence*, Flow, ChIP Magnetic, Chromatin IP-seq
- 12640: Western Blotting, Immunoprecipitation (Agarose), Immunofluorescence*, Flow, ChIP Magnetic, Chromatin IP-seq
- 94205: Western Blotting, Immunoprecipitation (Agarose), ChIP Magnetic
Product Description
The Stat3/Stat5 Signaling Antibody Sampler Kit provides an economical means of detecting the activation of Stat3, Stat5, and Jak2 using phospho-specific and control antibodies. The kit includes enough antibodies to perform two western blot experiments with each primary antibody.
Background
Janus kinases (Jaks) and signal transducers and activators of transcription (Stats) are utilized by receptors for a wide variety of ligands including cytokines, hormones, growth factors, and neurotransmitters. Jaks, activated via autophosphorylation following ligand-induced receptor aggregation, phosphorylate tyrosine residues on associated receptors, Stat molecules, and other downstream signaling proteins (1,2). The phosphorylation of Stat proteins at conserved tyrosine residues activates SH2-mediated dimerization followed rapidly by nuclear translocation. Stat dimers bind to interferon response element (IRE) and gamma interferon-activated sequence (GAS) DNA elements, resulting in the transcriptional regulation of downstream genes (1,2). The remarkable range and specificity of responses regulated by the Stats is determined in part by the tissue-specific expression of different cytokine receptors, Jaks and Stats (2,3), and by the combinatorial coupling of various Stat members to different receptors. Serine phosphorylation in the carboxy-terminal transcriptional activation domain has been shown to regulate the function of Stat1, Stat2, Stat3, Stat4, and Stat5 (1). Phosphorylation of Stat3 at Ser727 via MAPK or mTOR pathways is required for optimal transcriptional activation in response to growth factors and cytokines including IFN-gamma and ciliary neurotrophic factor (CNTF) (4,5). Jak/Stat pathways also play important roles in oncogenesis, tumor progression, angiogenesis, cell motility, immune responses, and stem cell differentiation (6-11).
In the context of hematopoiesis, Stat3 and Stat5 may act antagonistically (12,13). Stat3 activity can promote differentiation of myeloid progenitor cells into neutrophils in a granulocyte colony-stimulating factor (G-CSF)-dependent manner, while Stat5 activation results in inhibition of this pathway in a granulocyte-macrophage colony-stimulating factor (GM-CSF)-dependent manner (13). Stat5 activity upregulates SOCS3, which subsequently inhibits Stat3 and results in differentiation to monocytes and macrophages (13). In addition to their roles in regulating gene expression as transcription factors, Stat3 and Stat5 are also capable of altering chromatin landscapes through recruitment of chromatin remodeling enzymes (14,15). While they serve many key functions in normal growth and development, if disrupted, the Jak2/Stat3 and Jak2/Stat5 signaling axes contribute to various diseases, including many types of cancer, non-alcoholic fatty liver disease, and eosinophilic cellulitis (16-20).
In the context of hematopoiesis, Stat3 and Stat5 may act antagonistically (12,13). Stat3 activity can promote differentiation of myeloid progenitor cells into neutrophils in a granulocyte colony-stimulating factor (G-CSF)-dependent manner, while Stat5 activation results in inhibition of this pathway in a granulocyte-macrophage colony-stimulating factor (GM-CSF)-dependent manner (13). Stat5 activity upregulates SOCS3, which subsequently inhibits Stat3 and results in differentiation to monocytes and macrophages (13). In addition to their roles in regulating gene expression as transcription factors, Stat3 and Stat5 are also capable of altering chromatin landscapes through recruitment of chromatin remodeling enzymes (14,15). While they serve many key functions in normal growth and development, if disrupted, the Jak2/Stat3 and Jak2/Stat5 signaling axes contribute to various diseases, including many types of cancer, non-alcoholic fatty liver disease, and eosinophilic cellulitis (16-20).
- Darnell Jr., J. et al. (1994) Science 264, 1415-1421.
- Leonard, W.J. and O'Shea, J.J. (1998) Annu. Rev. Immunol. 16, 293-322.
- Caldenhoven, E. et al. (1996) J. Biol. Chem. 271, 13221-13227.
- Wen, Z. et al. (1995) Cell 82, 241-250.
- Yokogami, K. et al. (2000) Curr. Biol. 10, 47-50.
- Lim, C.P. and Cao, X. (1999) J. Biol. Chem. 274, 31055-31061.
- Bromberg, J. F. et al. (1999) Cell 98, 295-303.
- Su, L. et al. (1999) J. Biol. Chem. 274, 31770-31774.
- Dentelli, P. et al. (1999) J. Immunol. 163, 2151-2159.
- Cattaneo, E. et al. (1999) Trends Neurosci. 22, 365-369.
- Frank, D.A. (1999) Mol. Med. 5, 432-456.
- Cohen, P.A. et al. (2008) Blood 112, 1832-43.
- Zhang, M. et al. (2023) Cell Death Discov. 9, 274.
- Wingelhofer, B. et al. (2018) Leukemia 32, 1713-1726.
- Orlova, A. et al. (2019) Cancers (Basel) 11, 1930.
- Warsch, W. et al. (2013) Blood 122, 2167-75.
- Halim, C.E. et al. (2020) Biomedicines 8, 316.
- Huang, B. et al. (2022) Front. Oncol. 12, 1023177.
- Kaltenecker, D. et al. (2019) Cytokine 124, 154569.
- Morot, J. et al. (2023) JAMA Dermatol. 159, 820-829.
使用に関する制限
法的な権限を与えられたCSTの担当者が署名した書面によって別途明示的に合意された場合を除き、CST、その関連会社または代理店が提供する製品には以下の条件が適用されます。お客様が定める条件でここに定められた条件に含まれるものを超えるもの、または、ここに定められた条件と異なるものは、法的な権限を与えられたCSTの担当者が別途書面にて受諾した場合を除き、拒絶され、いかなる効力も効果も有しません。
研究専用 (For Research Use Only) またはこれに類似する表示がされた製品は、 いかなる目的についても FDA または外国もしくは国内のその他の規制機関により承認、認可または許可を受けていません。 お客様は製品を診断もしくは治療目的で使用してはならず、また、製品に表示された内容に違反する方法で使用してはなりません。 CST が販売または使用許諾する製品は、エンドユーザーであるお客様に対し、使途を研究および開発のみに限定して提供されるものです。 診断、予防もしくは治療目的で製品を使用することまたは製品を再販売 (単独であるか他の製品等の一部であるかを問いません) もしくはその他の商業的利用の目的で購入することについては、CST から別途許諾を得る必要があります。 お客様は以下の事項を遵守しなければなりません。(a) CST の製品 (単独であるか他の資材と一緒であるかを問いません) を販売、使用許諾、貸与、寄付もしくはその他の態様で第三者に譲渡したり使用させたりしてはなりません。また、商用の製品を製造するために CST の製品を使用してはなりません。(b) 複製、改変、リバースエンジニアリング、逆コンパイル、 分解または他の方法により製品の構造または技術を解明しようとしてはなりません。また、 CST の製品またはサービスと競合する製品またはサービスを開発する目的で CST の製品を使用してはなりません。(c) CST の製品の商標、商号、ロゴ、特許または著作権に関する通知または表示を除去したり改変したりしてはなりません。(d) CST の製品をCST 製品販売条件(CST’s Product Terms of Sale) および該当する書面のみに従って使用しなければなりません。(e) CST の製品に関連してお客様が使用する第三者の製品またはサービスに関する使用許諾条件、 サービス提供条件またはこれに類する合意事項を遵守しなければなりません。
For Research Use Only. Not for Use in Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
All other trademarks are the property of their respective owners. Visit our
Trademark Information page.